Back
Castellum, Inc. Vs. Monopar Therapeutics, Inc. Industry Stock Comparison
Sell
38
CTM
Castellum, Inc.
Last Price:
$1.03
Seasonality Move:
42.49%
Sell
36
MNPR
Monopar Therapeutics, Inc.
Last Price:
$71.60
Seasonality Move:
36.18%
Sell
38
Castellum, Inc. (CTM)
is a Sell
Is Castellum, Inc. a Buy, Sell or Hold?
-
The current Castellum, Inc. [CTM] share price is $1.03. The Score for CTM is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.
-
CTM is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
36
Monopar Therapeutics, Inc. (MNPR)
is a Sell
Is Monopar Therapeutics, Inc. a Buy, Sell or Hold?
-
The current Monopar Therapeutics, Inc. [MNPR] share price is $71.47. The Score for MNPR is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.
-
MNPR is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
CTM Stock Price Chart
What is Castellum, Inc.'s stock price today?
-
The Castellum, Inc. share price today is $1.03Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CTM is experiencing selling pressure, which indicates risk of future bearish movement.
MNPR Stock Price Chart
What is Monopar Therapeutics, Inc.'s stock price today?
-
The Monopar Therapeutics, Inc. share price today is $71.47Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MNPR is experiencing slight selling pressure.
CTM Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0 | Buy |
| Relative Strength Index (14 RSI): | 44.11 | Sell |
| Chaikin Money Flow: | -1602919 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.02 - 1.14) | Sell |
| Bollinger Bands (100): | (1.02 - 1.18) | Sell |
MNPR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -2.27 | Sell |
| Relative Strength Index (14 RSI): | 37.77 | Sell |
| Chaikin Money Flow: | -61015 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (75.54 - 86.44) | Sell |
| Bollinger Bands (100): | (44.45 - 88.87) | Buy |
CTM Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.12 | Sell |
| 20-day SMA: | 1.07 | Sell |
| 50-day SMA: | 1.08 | Sell |
| 200-day SMA: | 1.1 | Sell |
| 8-day EMA: | 1.09 | Sell |
| 20-day EMA: | 1.09 | Sell |
| 50-day EMA: | 1.09 | Sell |
| 200-day EMA: | 1.02 | Buy |
MNPR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 76.09 | Sell |
| 20-day SMA: | 80.86 | Sell |
| 50-day SMA: | 83.38 | Sell |
| 200-day SMA: | 51.78 | Buy |
| 8-day EMA: | 75.84 | Sell |
| 20-day EMA: | 78.85 | Sell |
| 50-day EMA: | 77.98 | Sell |
| 200-day EMA: | 56.35 | Buy |
Castellum, Inc. Earnings Growth & CTM Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Monopar Therapeutics, Inc. Earnings Growth & MNPR Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.58 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.10 per share, and a decrease next year of $1.78 per share.
Castellum, Inc. Technical Analysis
| Dec 3 | Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 03 | 04 | 05 | 08 | 09 | 10 | 11 | 12 | 15 | 16 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Monopar Therapeutics, Inc. Technical Analysis
| Dec 3 | Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 03 | 04 | 05 | 08 | 09 | 10 | 11 | 12 | 15 | 16 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||